Microbix Historical Income Statement

MBX Stock

CAD 0.30 0.01 3.45%

Historical analysis of Microbix Biosystems income statement accounts such as Total Revenue of 30.7 M can show how well Microbix Biosystems performed in making a profits. Evaluating Microbix Biosystems income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Microbix Biosystems's future profits or losses.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Microbix Biosystems latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Microbix Biosystems is a good buy for the upcoming year.

Net Income Gross Profit

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microbix Biosystems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Microbix Income Statement Analysis

Microbix Biosystems Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Microbix Biosystems shareholders. The income statement also shows Microbix investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Microbix Biosystems Income Statement Chart

At this time, Microbix Biosystems' Operating Income is very stable compared to the past year. As of the 23rd of July 2025, EBIT is likely to grow to about 965.9 K, while Selling And Marketing Expenses is likely to drop about 784.7 K.

Selling General Administrative Total Revenue Gross Profit Other Operating Expenses

Total Revenue

Total revenue comprises all receipts Microbix Biosystems generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Microbix Biosystems minus its cost of goods sold. It is profit before Microbix Biosystems operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Microbix Biosystems. It is also known as Microbix Biosystems overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from Microbix Biosystems' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Microbix Biosystems current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microbix Biosystems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2022	2023	2024	2025 (projected)
Gross Profit	7.5M	15.4M	17.7M	18.6M
Total Revenue	16.5M	25.4M	29.2M	30.7M

Gross Profit Total Revenue

Microbix Biosystems income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Total Other Income Expense Net	Net Income	Income Tax Expense	Income Before Tax	Selling And Marketing Expenses	Net Income From Continuing Ops	Tax Provision	Net Interest Income	Interest Income	Reconciled Depreciation
Depreciation And Amortization		-0.07	0.95	0.95	0.91	0.99	0.57	0.21	0.93	0.33	0.97	0.89	0.48	0.46	0.2	0.54	0.36	0.42	0.37	0.45	0.87	0.86
Interest Expense	-0.07		-0.24	-0.09	-0.16	-0.02	-0.04	0.07	-0.32	0.06	0.05	-0.35	-0.43	-0.31	0.05	-0.15	-0.35	-0.21	0.16	-0.75	-0.43	-0.28
Selling General Administrative	0.95	-0.24		0.96	0.94	0.96	0.61	0.18	0.93	0.29	0.93	0.98	0.56	0.54	0.22	0.58	0.27	0.49	0.27	0.56	0.95	0.86
Total Revenue	0.95	-0.09	0.96		0.98	0.96	0.75	0.29	0.89	0.4	0.96	0.94	0.49	0.58	0.21	0.65	0.24	0.53	0.27	0.41	0.88	0.84
Gross Profit	0.91	-0.16	0.94	0.98		0.9	0.83	0.37	0.88	0.47	0.9	0.94	0.55	0.67	0.27	0.73	0.26	0.62	0.22	0.42	0.87	0.83
Other Operating Expenses	0.99	-0.02	0.96	0.96	0.9		0.55	0.18	0.91	0.3	0.99	0.88	0.45	0.44	0.16	0.52	0.28	0.4	0.32	0.43	0.86	0.83
Operating Income	0.57	-0.04	0.61	0.75	0.83	0.55		0.56	0.53	0.62	0.58	0.65	0.38	0.69	0.32	0.76	0.13	0.68	0.15	0.05	0.53	0.56
Ebit	0.21	0.07	0.18	0.29	0.37	0.18	0.56		0.2	0.99	0.14	0.19	0.68	0.85	0.71	0.88	0.3	0.87	-0.21	-0.02	0.2	0.22
Research Development	0.93	-0.32	0.93	0.89	0.88	0.91	0.53	0.2		0.31	0.85	0.9	0.57	0.53	0.2	0.54	0.4	0.45	0.29	0.58	0.9	0.84
Ebitda	0.33	0.06	0.29	0.4	0.47	0.3	0.62	0.99	0.31		0.25	0.29	0.72	0.88	0.72	0.91	0.33	0.89	-0.16	0.04	0.3	0.32
Cost Of Revenue	0.97	0.05	0.93	0.96	0.9	0.99	0.58	0.14	0.85	0.25		0.87	0.37	0.39	0.11	0.48	0.19	0.35	0.34	0.36	0.82	0.81
Total Operating Expenses	0.89	-0.35	0.98	0.94	0.94	0.88	0.65	0.19	0.9	0.29	0.87		0.61	0.6	0.24	0.62	0.31	0.55	0.24	0.64	0.97	0.85
Total Other Income Expense Net	0.48	-0.43	0.56	0.49	0.55	0.45	0.38	0.68	0.57	0.72	0.37	0.61		0.88	0.69	0.84	0.56	0.87	-0.15	0.64	0.7	0.55
Net Income	0.46	-0.31	0.54	0.58	0.67	0.44	0.69	0.85	0.53	0.88	0.39	0.6	0.88		0.61	0.98	0.39	0.98	-0.23	0.43	0.6	0.51
Income Tax Expense	0.2	0.05	0.22	0.21	0.27	0.16	0.32	0.71	0.2	0.72	0.11	0.24	0.69	0.61		0.67	0.3	0.64	0.24	0.04	0.26	0.23
Income Before Tax	0.54	-0.15	0.58	0.65	0.73	0.52	0.76	0.88	0.54	0.91	0.48	0.62	0.84	0.98	0.67		0.35	0.96	-0.09	0.33	0.61	0.55
Selling And Marketing Expenses	0.36	-0.35	0.27	0.24	0.26	0.28	0.13	0.3	0.4	0.33	0.19	0.31	0.56	0.39	0.3	0.35		0.46	0.01	0.44	0.39	0.54
Net Income From Continuing Ops	0.42	-0.21	0.49	0.53	0.62	0.4	0.68	0.87	0.45	0.89	0.35	0.55	0.87	0.98	0.64	0.96	0.46		-0.26	0.35	0.55	0.47
Tax Provision	0.37	0.16	0.27	0.27	0.22	0.32	0.15	-0.21	0.29	-0.16	0.34	0.24	-0.15	-0.23	0.24	-0.09	0.01	-0.26		-0.11	0.19	0.29
Net Interest Income	0.45	-0.75	0.56	0.41	0.42	0.43	0.05	-0.02	0.58	0.04	0.36	0.64	0.64	0.43	0.04	0.33	0.44	0.35	-0.11		0.73	0.54
Interest Income	0.87	-0.43	0.95	0.88	0.87	0.86	0.53	0.2	0.9	0.3	0.82	0.97	0.7	0.6	0.26	0.61	0.39	0.55	0.19	0.73		0.85
Reconciled Depreciation	0.86	-0.28	0.86	0.84	0.83	0.83	0.56	0.22	0.84	0.32	0.81	0.85	0.55	0.51	0.23	0.55	0.54	0.47	0.29	0.54	0.85

Click cells to compare fundamentals

Microbix Biosystems Account Relationship Matchups

Microbix Biosystems income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Depreciation And Amortization	690.1K	822.0K	1.0M	1.2M	1.3M	1.4M
Interest Expense	1.6M	826.6K	839.4K	392.3K	451.2K	536.4K
Selling General Administrative	4.2M	5.0M	6.5M	8.9M	10.2M	10.7M
Total Revenue	18.6M	19.1M	16.5M	25.4M	29.2M	30.7M
Gross Profit	11.0M	11.1M	7.5M	15.4M	17.7M	18.6M
Other Operating Expenses	11.0M	13.8M	16.5M	19.3M	22.1M	23.2M
Operating Income	4.8M	2.7M	(2.7M)	3.7M	4.2M	4.4M
Ebit	(3.6M)	4.8M	2.7M	799.9K	919.9K	965.9K
Research Development	1.0M	1.8M	2.0M	2.1M	2.4M	2.6M
Ebitda	(2.9M)	5.7M	3.7M	2.0M	2.3M	2.4M
Cost Of Revenue	7.5M	8.0M	9.0M	10.0M	11.5M	12.1M
Total Operating Expenses	6.2M	8.5M	10.2M	21.5M	24.7M	25.9M
Total Other Income Expense Net	(4.1M)	(1.6M)	(744.3K)	2.7M	2.4M	2.5M
Net Income	1.6M	1.8M	(39.5K)	3.5M	4.0M	4.3M
Income Tax Expense	1.6M	1.6M	77.2K	839.4K	755.4K	793.2K
Income Before Tax	3.2M	1.9M	(39.5K)	3.7M	4.2M	4.4M
Selling And Marketing Expenses	632.6K	858.1K	1.6M	1.5M	1.3M	784.7K
Net Income From Continuing Ops	3.2M	1.8M	(39.5K)	3.5M	4.0M	4.3M
Net Income Applicable To Common Shares	3.2M	1.8M	(39.5K)	3.5M	4.0M	4.3M
Net Interest Income	(1.6M)	(744.3K)	(381.6K)	(234.3K)	(269.4K)	(282.9K)
Reconciled Depreciation	822.0K	1.0M	1.2M	1.6M	1.9M	974.5K

Pair Trading with Microbix Biosystems

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Microbix Biosystems position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Microbix Biosystems will appreciate offsetting losses from the drop in the long position's value.

Moving together with Microbix Stock

0.82

BRK

Berkshire Hathaway CDR

Pair Corr

Moving against Microbix Stock

0.87	AUAU	Allegiant Gold Split	Pair Corr
0.79	RKV	Rakovina Therapeutics Split	Pair Corr
0.78	GOOG	Alphabet CDR	Pair Corr
0.77	AMZN	Amazon CDR	Pair Corr
0.77	META	Meta Platforms CDR Earnings Call This Week	Pair Corr

The ability to find closely correlated positions to Microbix Biosystems could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microbix Biosystems when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microbix Biosystems - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microbix Biosystems to buy it.

The correlation of Microbix Biosystems is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microbix Biosystems moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microbix Biosystems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Microbix Biosystems can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Other Information on Investing in Microbix Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC

Microbix Historical Income Statement

About Microbix Income Statement Analysis

Microbix Biosystems Income Statement Chart

Total Revenue

Gross Profit

Other Operating Expenses

Microbix Biosystems income statement Correlations

Microbix Biosystems Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Microbix Biosystems income statement Accounts

Pair Trading with Microbix Biosystems

Moving together with Microbix Stock

Moving against Microbix Stock

Other Information on Investing in Microbix Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Other Operating Expenses	+ 0.99	Depreciation And Amortization
Cost Of Revenue	+ 0.99	Other Operating Expenses
Ebitda	+ 0.99	Ebit
Total Operating Expenses	+ 0.98	Selling General Administrative
Gross Profit	+ 0.98	Total Revenue
Income Before Tax	+ 0.98	Net Income

Net Interest Income	- 0.75	Interest Expense
Interest Income	- 0.43	Interest Expense
Total Other Income Expense Net	- 0.43	Interest Expense
Selling And Marketing Expenses	- 0.35	Interest Expense
Total Operating Expenses	- 0.35	Interest Expense
Research Development	- 0.32	Interest Expense